Aktie • Biotechnologie
Zugehörige Wertpapiere Cerevel Therapeutics
- WKN
- A2QF3L
- ISIN
- US15678U1280
- Ticker
- CERE • 673
- WKN
- A2QF3L
- Ticker
- CERE • 673
- ISIN
- US15678U1280
•
40,910 USD
+0,280 USD+0,69 %
Geld
20,000 USD
(100 Stk.)
Brief
44,810 USD
(100 Stk.)
Zugehörige Fonds zur Cerevel Therapeutics Aktie
| Name | KVG | Anteil am Fonds |
|---|---|---|
AB SICAV I Event Driven Portfolio - I USD ACC WKN A3CRVA · ISIN LU2275027386 | AllianceBernstein | 3,70 % |
AB SICAV I Event Driven Portfolio - I EUR ACC H WKN A3DJ0T · ISIN LU2275027469 | AllianceBernstein | 3,70 % |
AB SICAV I Event Driven Portfolio - I GBP ACC H WKN A3D3ND · ISIN LU2561636593 | AllianceBernstein | 3,70 % |
Man GLG Event Driven Alternative - INF EUR ACC H WKN A2PRCP · ISIN IE00BJBLGJ52 | Man Group | 3,60 % |
Man GLG Event Driven Alternative - IN USD ACC WKN A2PZ6V · ISIN IE00BJJNGV56 | Man Group | 3,60 % |
Man GLG Event Driven Alternative - DN EUR ACC H WKN A2P1EB · ISIN IE00BJBLGL74 | Man Group | 3,60 % |
Man GLG Event Driven Alternative - INF USD ACC WKN A2PWEX · ISIN IE00BJBLGK67 | Man Group | 3,60 % |
Man GLG Event Driven Alternative - IN SEK ACC H WKN A2QM13 · ISIN IE00BJJNGY87 | Man Group | 3,60 % |
Man GLG Event Driven Alternative - IN EUR ACC H WKN A2PNJV · ISIN IE00BJJNH014 | Man Group | 3,60 % |